Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System

Cytotherapy

Volumn 15, Issue 11, 2013, Pages 1323-1339

  Jones, Mark ^a   Varella Garcia, Marileila ^b   Skokan, Margaret ^b   Bryce, Steven ^c   Schowinsky, Jeffrey ^d   Peters, Rebecca ^a   Vang, Boah ^a   Brecheisen, Michelle ^a   Startz, Thomas ^a   Frank, Nathan ^a   Nankervis, Brian ^a  

^a Terumo BCT Inc   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c LITRON LABORATORIES   (United States)

^d UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

Cell proliferation; Chromosome; Mesenchymal stromal cell; Micronucleus; Spectral karyotyping; Xenograft

Indexed keywords

POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; AUTOMATION; BONE MARROW BIOPSY; BONE MARROW DERIVED MESENCHYMAL STROMA CELL; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL SELECTION; CELL STRUCTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; DONOR; GENERAL DEVICE; GENETIC STABILITY; HOLLOW FIBER BASED DEVICE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPE; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMAL STROMA CELL; MICRONUCLEUS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; TISSUE CULTURE;

MUS;

CELL PROLIFERATION; CHROMOSOME; MESENCHYMAL STROMAL CELL; MICRONUCLEUS; SPECTRAL KARYOTYPING; XENOGRAFT;

ADULT; ANIMALS; BONE MARROW CELLS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROGENESIS; FEMALE; GENETIC VARIATION; GENOMIC INSTABILITY; HETEROGRAFTS; HUMANS; KARYOTYPE; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TISSUE CULTURE TECHNIQUES; YOUNG ADULT;

EID: 84884986757     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.05.024     Document Type: Article

References (35)

1. Friedenstein A.J., Piatetzky-Shaprio, Petrakova K.V. Osteogenesis in transplants of bone marrow cells. JEmbryol Exp Morph 1966, 16:381-390.
2. Friedenstein A.J., Petrakova K.V., Kurolesova K.I., Frolova G.P. Heterotopic transplants of bone marrow. Transplantation 1968, 6:230-247.
3. Latsinik N.V., Luria E.A., Friedenstein A.J., Samoylina N.L., Chertkov J.L. Colony-forming cells in organ cultures of embryonal liver. JCell Physiol 1970, 75:163-166.
4. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9-20.
5. Dominici M., Le Blanc K., Slaper-Cortenbach I., Marini F.C., Krause D.S., Deans R.J., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-331.
6. Wang Y., Huso D.L., Harrington J., Kellner J., Jeong D.K., Turney J., McNiece I.K. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005, 7:509-519.
7. Varella-Garcia M., Chen L., Powell R.L., Hirsch F.R., Kennedy T.C., Keith R., et al. Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. Am J Respir Crit Care Med 2007, 176:505-512.
8. Mateuca R., Lombaert N., Aka P.V., Decordier I., Kirsch-Volders M. Chromosomal changes: induction, detection methods and applicability in human biomonitoring. Biochimie 2006, 88:1515-1531.
9. Fenech M., Kirsch-Volders M., Natarajan A.T., Surrallas J., Crott J.W., Parry J., et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 2011, 26:125-132.
10. Savage JRK. Micronuclei: pitfalls and problems. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2000. Accessed online June 8, 2012. http://AtlasGeneticsOncology.org/Deep/MicronucleiID20016.html.
11. Bryce S., Bemis J.C., Avlasevich S.L., Dertinger S.D. In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity. Mutat Res 2007, 630:78-91.
12. Rygaard J., Povlsen C.O. Heterotransplantation of a human malignant tumour to "nude" mice. Acta Pathol Microbiol Scand 1969, 77:758-760.
13. Rygaard J., Povlsen C.O. The nude mouse vs. the hypothesis of immunological surveillance. Transplant Rev 1976, 28:43-61.
14. Shaffer LG, Slovak ML, Campbell LJ. International Standing Committee on Human Cytogenetic Nomenclature. An International System for Human Cytogenetic Nomenclature. ISCN, Basel 2009.
15. Bryce S.M., Avlasevich S.L., Bemis J.C., Lukamowicz M., Elhajouji A., Van Goethem F., et al. Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay. Mutat Res 2008, 650:181-195.
16. Nicolette J., Diehl M., Sohnders P., Bryce S., Blomme E. In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells. Environ Mol Mutagen 2011, 52:355-362.
17. Avlasevich S., Bryce S., De Boeck M., Elhajouji A., Van Goethem F., Lynch A., et al. Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present, and future. Mutagenesis 2011, 26:147-152.
18. Hashimoto Y., Shudo K. Chemical modification of DNA with MutaCarcinogens. III. Reductive alkylation of DNA with mitomycin C. Environ Health Perspect 1985, 62:219-222.
19. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
20. Euhus D.M., Hudd C., LaRegina M., Johnson F. Tumor measurement in the nude mouse. JSurg Oncol 1986, 21:229-234.
21. Demma M., Maxwell E., Ramos R., Liang L., Li C., Hesk D., et al. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53. JBiol Chem 2010, 285:10198-10212.
22. Rojewski M., Fekete N., Baila S., Nguyen K., Fürst D., Antwiler D., et al. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device Quantum Cell Expansion System. Cell Transplant 2012, [published online ahead of print October 25, 2012], Accessed on March 6, 2013. doi:10.3727/096368912X657990.
23. Mets T., Verdonk G. Variation in the stromal cell population of human bone marrow during aging. Mech Ageing Dev 1981, 15:41-49.
24. Montesinos J.J., Flores-Figueroa E., Castillo-Medina S., Flores-Guzmán P., Hernández-Estévez E., Fajardo-Orduna G., et al. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009, 11:163-176.
25. Jung S., Panchalingam K., Rosenberg L., Behie L. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int 2012, 2012:1-21. Accessed online December 11, 2012. http://dx.doi.org/10.115/2012/123030.
26. Ra J.C., Shin I.S., Kim S.H., Kang S.K., Kang B.C., Lee H.Y., et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011, 20:1297-1308.
27. Wang Y., Huso D.L., Harrington J., Kellner J., Jeong D.K., Turney J., et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005, 7:509-519.
28. Li N., Yang R., Zhang W., Dorfman H., Rao P., Gorlick R. Genetically transforming human mesenchymal stem cells tosarcomas. Cancer 2009 Oct 15, 115:4795-4806. Accessed on May 29, 2012. doi:10.1002/cncr.24519.
29. Loring J.F., Rao M.S. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 2006, 24:145-150.
30. Serkinci N., Guldberg P., Burns J.S., Abdallah B., Schrødder H., Jensen T., et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004, 23:5095-5098.
31. Miura M., Miura Y., Padilla-Nash H.M., Molinolo A.A., Fu B., Patel V., et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006, 24:1095-1103.
32. Gisselsson D., Björk J., Höglund M., Mertens F., Dal Cin P., Akerman M., et al. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 2001, 158:199-206.
33. Ebert R., Ulmer M., Zeck S., Messner-Weigl J., Schneider D., Stopper H., et al. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow cells in vitro. Stem Cells 2006, 24:1226-1235.
34. Giordano A., Galderisi U., Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. JCell Physiol 2007, 211:27-35.
35. Lund T.C., Kobs A., Blazar B.R., Tolar J. Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions. Cytotherapy 2010, 12:971-981.